S. Barrans, S. Crouch, and A. Smith, Is Associated With Poor Prognosis in Patients With Diffuse Large B-Cell Lymphoma Treated in the Era of Rituximab, Journal of Clinical Oncology, vol.28, issue.20
DOI : 10.1200/JCO.2009.26.3947

C. Copie-bergman, P. Gaulard, and K. Leroy, Immuno???Fluorescence In Situ Hybridization Index Predicts Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP: A GELA Study, Journal of Clinical Oncology, vol.27, issue.33, pp.5573-5579, 2009.
DOI : 10.1200/JCO.2009.22.7058

URL : https://hal.archives-ouvertes.fr/inserm-00424929

W. Klapper, H. Stoecklein, and S. Zeynalova, Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL), Leukemia, vol.103, issue.12, pp.2226-2229, 2008.
DOI : 10.1038/leu.2008.230

N. Nitsu, M. Okamoto, I. Miura, and M. Hirano, translocation in diffuse large B-cell lymphoma, Cancer Science, vol.19, issue.2, pp.233-237, 2009.
DOI : 10.1111/j.1349-7006.2008.01035.x

K. Savage, N. Johnson, and S. En-neriah, MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy, Blood, vol.114, issue.17, pp.3533-3537, 2009.
DOI : 10.1182/blood-2009-05-220095

P. Kluin and H. Stein, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues: B-Cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma, 2008.

L. Quintanilla-martinez, D. De-jong, and A. De-mascarel, Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux, France, Journal of Hematopathology, vol.138, issue.1, pp.211-236, 2009.
DOI : 10.1007/s12308-009-0053-9

S. Aukema, R. Siebert, and E. Schuuring, Double-hit B-cell lymphomas, Blood, vol.117, issue.8, pp.2319-2331, 2011.
DOI : 10.1182/blood-2010-09-297879

A. Kanungo, L. Medeiros, L. Abruzzo, and P. Lin, Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis, Modern Pathology, vol.19, issue.1
DOI : 10.1038/modpathol.3800500

L. Gouill, S. Talmant, P. Touzeau, and C. , The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14

S. Smith, J. Anastasi, K. Cohen, and L. Godley, The impact of MYC expression in lymphoma biology: Beyond Burkitt lymphoma, Blood Cells, Molecules, and Diseases, vol.45, issue.4, pp.317-323, 2010.
DOI : 10.1016/j.bcmd.2010.08.002

M. Tibiletti, V. Martin, B. B. Bcl2, . Bcl6, and . Myc, BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome, Human Pathology, vol.40, issue.5, pp.645-652, 2009.
DOI : 10.1016/j.humpath.2008.06.032

K. Dunleavy, S. Pittaluga, and A. Wayne, MYC aggressive-B-cell lymphomas: novel therapy of untreated Burekitt (BL) and MYC diffuse large B-cell lymphoma (DLBCL + + with DA-EPOCH-B, Ann Oncol, vol.22, 2011.

G. Gisselbrecht, B. Glass, and N. Mounier, Maintenance with rituximab after autologous stem cell transplantation in relapsed patients with CD20 diffuse large B-cell lymphoma (DLBCL): CORAL final analysis., Journal of Clinical Oncology, vol.29, issue.15_suppl, p.2011
DOI : 10.1200/jco.2011.29.15_suppl.8004

E. Haralambieva, K. Kleiverda, D. Mason, E. Schuuring, and P. Kluin, Detection of three common translocation breakpoints in non-Hodgkin's lymphomas by fluorescencein situ hybridization on routine paraffin-embedded tissue sections, The Journal of Pathology, vol.110, issue.2, pp.163-170, 2002.
DOI : 10.1002/path.1197

C. Thieblemont, J. Briere, and N. Mounier, The Germinal Center/Activated B-Cell Subclassification Has a Prognostic Impact for Response to Salvage Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Bio-CORAL Study, Journal of Clinical Oncology, vol.29, issue.31, pp.4079-4087, 2011.
DOI : 10.1200/JCO.2011.35.4423

C. Hans, D. Weisenburger, and T. Greiner, Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray, Blood, vol.103, issue.1, pp.275-282, 2004.
DOI : 10.1182/blood-2003-05-1545

J. Muris, C. Meijer, and W. Vos, Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma, The Journal of Pathology, vol.3, issue.5, pp.714-723, 2006.
DOI : 10.1002/path.1924

H. Nyman, M. Jerkeman, M. Karjalainen-lindsberg, A. Banham, and S. Leppa, Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOP, Modern Pathology, vol.329, issue.8, pp.1094-1101, 2009.
DOI : 10.1111/j.1365-2559.2007.02721.x

A. Alizadeh, M. Eisen, and R. Davis, Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling, Nature, vol.303, issue.6769, pp.503-511, 2000.
DOI : 10.1038/35000501

E. Kaplan and P. Meier, Non parametric estimation from incomplete observations, J Am Stat Assoc, vol.153, pp.457-481, 1958.

D. Cox, Regression Models and Life-Tables, J R Stat Soc B, vol.34, pp.187-220, 1972.
DOI : 10.1007/978-1-4612-4380-9_37